CryoLife, Inc. (NYSE:CRY)

CAPS Rating: 5 out of 5

The Company develops and commercializes biomaterials, implantable medical devices, and preserves and distributes human tissues for cardiovascular and vascular transplant applications.

Recs

0
Player Avatar dannp (63.47) Submitted: 8/25/2008 4:16:22 PM : Outperform Start Price: $14.29 CRY Score: -75.02

I would love to see this company explode and make it to the top. With the way america's health is according to the news we'll all be needing this company to prosper. I'm hoping they have a good board of directors to lead them into the future.

Featured Broker Partners


Advertisement